LEADER 03097nam  2200637   450 
001 9910789239703321
005 20230803034625.0
010   $a0-309-26641-6
010   $a0-309-26639-4
035   $a(CKB)3710000000103186
035   $a(EBL)3379043
035   $a(SSID)ssj0001219180
035   $a(PQKBManifestationID)11817691
035   $a(PQKBTitleCode)TC0001219180
035   $a(PQKBWorkID)11214205
035   $a(PQKB)10901761
035   $a(MiAaPQ)EBC3379043
035   $a(Au-PeEL)EBL3379043
035   $a(CaPaEBR)ebr10863690
035   $a(OCoLC)863088236
035   $a(EXLCZ)993710000000103186
100   $a20140206h20132013  uy|            0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aRanking vaccines $ea prioritization software tool. Phase II, Prototype of a decision-support system /$fCommittee on Identifying and Prioritizing New Preventive Vaccines for Development, Phase II, Board on Population Health and Public Health Practice, Board on Global Health ; Guruprasad Madhavan [and six others], editors ; Institute of Medicine of the National Academies
210  1$aWashington, District of Columbia :$cThe National Academies Press,$d[2013]
210  4$dİ2013
215   $a1 online resource (161 p.)
300   $aDescription based upon print version of record.
311   $a0-309-26638-6 
320   $aIncludes bibliographical references.
327   $a""Front Matter""; ""Reviewers""; ""Foreword""; ""Preface""; ""Contents""; ""Disclaimer""; ""Summary""; ""1 Introduction: New Vaccines and SMART Vaccines""; ""2 Refinements to the SMART Vaccines Model""; ""3 Data Synthesis, Software Redesign, and Evaluation""; ""4 Observations and Looking Forward""; ""References""; ""Appendix A: Computational Modeling for SMART Vaccines""; ""Appendix B: Candidate Disease Profiles""; ""Appendix C: Data Sources and Methodology for SMART Vaccines""; ""Appendix D: Verification and Analyses of the SMART Vaccines Computational Model""
327   $a""Appendix E: Stakeholder Speakers""""Appendix F: Biographical Information""
606   $aVaccines$xDevelopment$zUnited States$xDecision making
606   $aVaccines industry$zUnited States$xDecision making
606   $aResource allocation$zUnited States
606   $aResource allocation$zUnited States$vSoftware
615  0$aVaccines$xDevelopment$xDecision making.
615  0$aVaccines industry$xDecision making.
615  0$aResource allocation
615  0$aResource allocation
676   $a615.3/72
702   $aMadhavan$b Guruprasad
712 02$aInstitute of Medicine (U.S.).$bCommittee on Identifying and Prioritizing New Preventive Vaccines for Development,
712 02$aInstitute of Medicine (U.S.).$bBoard on Population Health and Public Health Practice,
712 02$aInstitute of Medicine (U.S.).$bBoard on Global Health,
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910789239703321
996   $aRanking vaccines$93698962
997   $aUNINA